DE60025526D1 - Elisa für vegf - Google Patents

Elisa für vegf

Info

Publication number
DE60025526D1
DE60025526D1 DE60025526T DE60025526T DE60025526D1 DE 60025526 D1 DE60025526 D1 DE 60025526D1 DE 60025526 T DE60025526 T DE 60025526T DE 60025526 T DE60025526 T DE 60025526T DE 60025526 D1 DE60025526 D1 DE 60025526D1
Authority
DE
Germany
Prior art keywords
vegf
diagnostic
prognostic index
elisa
pathologies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60025526T
Other languages
English (en)
Other versions
DE60025526T2 (de
Inventor
Tai Fei
K Tomita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DE60025526D1 publication Critical patent/DE60025526D1/de
Publication of DE60025526T2 publication Critical patent/DE60025526T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/809—Multifield plates or multicontainer arrays
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
DE60025526T 1999-11-16 2000-11-15 Elisa für vegf Expired - Lifetime DE60025526T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16573699P 1999-11-16 1999-11-16
US165736P 1999-11-16
PCT/US2000/031427 WO2001036972A2 (en) 1999-11-16 2000-11-15 Elisa for vegf

Publications (2)

Publication Number Publication Date
DE60025526D1 true DE60025526D1 (de) 2006-04-06
DE60025526T2 DE60025526T2 (de) 2006-08-24

Family

ID=22600234

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60025526T Expired - Lifetime DE60025526T2 (de) 1999-11-16 2000-11-15 Elisa für vegf

Country Status (14)

Country Link
US (2) US6855508B2 (de)
EP (1) EP1230552B1 (de)
JP (1) JP4620312B2 (de)
KR (1) KR100749982B1 (de)
CN (1) CN100399030C (de)
AT (1) ATE315789T1 (de)
AU (1) AU774575C (de)
CA (1) CA2387390C (de)
DE (1) DE60025526T2 (de)
ES (1) ES2256066T3 (de)
IL (2) IL149171A0 (de)
NZ (1) NZ518363A (de)
WO (1) WO2001036972A2 (de)
ZA (1) ZA200202942B (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE315789T1 (de) * 1999-11-16 2006-02-15 Genentech Inc Elisa für vegf
US20020137098A1 (en) * 2000-10-20 2002-09-26 Board Of Regents, The University Of Texas System Methods for detecting retinopathy of prematurity
US20050009110A1 (en) * 2003-07-08 2005-01-13 Xiao-Jia Chang Methods of producing antibodies for diagnostics and therapeutics
US7758859B2 (en) 2003-08-01 2010-07-20 Genentech, Inc. Anti-VEGF antibodies
US20050106667A1 (en) 2003-08-01 2005-05-19 Genentech, Inc Binding polypeptides with restricted diversity sequences
WO2005012531A2 (en) * 2003-08-01 2005-02-10 Genentech, Inc. Antibody cdr polypeptide sequences with restricted diversity
EP1769243A2 (de) 2004-05-15 2007-04-04 Genentech, Inc. Kreuzscreening-system und verfahren für den nachweis eines moleküls mit bindungsaffinität für ein zielmolekül
CA2511269A1 (en) * 2004-07-07 2006-01-07 F. Hoffmann-La Roche Ag Multimarker panel based on p1gf for diabetes type 1 and 2
CN1316249C (zh) * 2004-08-25 2007-05-16 北京健平九星生物医药科技有限公司 一种酶联检测试剂盒及制备方法
US7595149B1 (en) 2004-11-08 2009-09-29 University Of Kentucky Research Foundation Methods for cancer detection
AU2013221919B2 (en) * 2006-10-04 2016-04-14 Genentech, Inc. ELISA for VEGF
CN101523220B (zh) * 2006-10-04 2016-09-21 健泰科生物技术公司 针对vegf的elisa
WO2008079322A1 (en) * 2006-12-22 2008-07-03 Beckman Coulter, Inc. Methods, kits and materials for diagnosing disease states by measuring isoforms or proforms of myeloperoxidase
US20080160638A1 (en) * 2006-12-27 2008-07-03 David Lederman Functionalized Microcantilever Sensor and Associated Method For Detection of Targeted Analytes
DE102007038730A1 (de) * 2007-08-16 2009-02-19 Carl Zeiss Meditec Ag Nachweis des menschlichen Vascular Endothelial Growth Factor
TWI580694B (zh) 2007-11-30 2017-05-01 建南德克公司 抗-ｖｅｇｆ抗體
JP2011513753A (ja) * 2008-03-05 2011-04-28 シンギュレックス・インコーポレイテッド 分子の高感度検出の方法および組成物
US7772006B2 (en) 2008-08-21 2010-08-10 Paul Tornambe Agent detection and/or quantitation in a biological fluid
CN102144161B (zh) 2008-09-04 2016-02-17 贝克曼考尔特公司 泛激酶活化与信号通路的评估
ES2640900T3 (es) * 2008-10-30 2017-11-07 Firalis Biomarcadores
US8349325B2 (en) * 2008-12-23 2013-01-08 Abbott Laboratories Soluble FMS-like tyrosine kinase-1 (sFLT-1) antibody and related composition, kit, methods of using, and materials and method for making
EP2488661B1 (de) 2009-10-14 2014-12-24 Oberbauer, Rainer Prüfung auf Risiko einer akuten Nierenverletzung
WO2011057347A1 (en) 2009-11-12 2011-05-19 Tgr Biosciences Pty Ltd Analyte detection
US20120004132A1 (en) * 2010-07-02 2012-01-05 Affymetrix, Inc. Detection of Nucleic Acids and Proteins
WO2012010549A1 (en) 2010-07-19 2012-01-26 F. Hoffmann-La Roche Ag Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy
SG187120A1 (en) 2010-07-19 2013-02-28 Hoffmann La Roche Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy
ES2555864T3 (es) 2010-08-19 2016-01-11 F. Hoffmann-La Roche Ag Ensayo para la medición de anticuerpos de unión a un anticuerpo monoclonal terapéutico
WO2012030738A2 (en) 2010-08-30 2012-03-08 Beckman Coulter, Inc. Complex phosphoprotein activation profiles
WO2012098203A1 (en) * 2011-01-21 2012-07-26 Basilea Pharmaceutica Ag Use of glu-tubulin as a biomarker of drug response to furazanobenzimidazoles
WO2012113718A1 (en) 2011-02-21 2012-08-30 Roche Diagnostics Gmbh A diagnostic method for type ii diabetes
WO2012129610A1 (en) * 2011-03-31 2012-10-04 Tgr Biosciences Pty Ltd One-step immunoassay detection of analytes
CN102323421A (zh) * 2011-05-24 2012-01-18 北京健平九星生物医药科技有限公司 一种酶联检测试剂盒及其制备方法
FR2976076B1 (fr) * 2011-05-31 2015-02-27 Imabiotech Procede de detection et de quantification d'une molecule cible dans un tissu
CN102435743B (zh) * 2011-09-15 2014-10-15 北京健平九星生物医药科技有限公司 一种酶联检测试剂盒及其制备方法
US20130149386A1 (en) * 2011-12-07 2013-06-13 Region Nordjylland Cd36 as biomarker for steatosis
EP2795335B1 (de) * 2011-12-19 2017-09-06 F. Hoffmann-La Roche AG Verfahren zur detektion des freien bindungspartners eines multispezifischen bindemittels
WO2013113663A1 (en) * 2012-02-01 2013-08-08 F. Hoffmann-La Roche Ag Method for the detection of a binding partner of a multispecific binder
CN104471397B (zh) 2012-07-13 2018-03-23 弗·哈夫曼-拉罗切有限公司 用于检测多特异性结合物的方法
EP2954332A1 (de) 2013-02-06 2015-12-16 Pieris AG Neuartige lipocalinmuteintests zur messung der hepcidinkonzentration
CN106153935B (zh) * 2015-03-26 2018-05-08 广州瑞博奥生物科技有限公司 一种定量检测CD79α的酶联免疫试剂盒
CN106153934B (zh) * 2015-03-26 2018-06-19 广州瑞博奥生物科技有限公司 一种高效定量检测高尔基体73的试剂盒
CN106153933B (zh) * 2015-03-26 2018-09-04 广州瑞博奥生物科技有限公司 一种高效定量检测c反应蛋白的免疫学试剂盒
CN116987187A (zh) 2015-09-23 2023-11-03 豪夫迈·罗氏有限公司 抗-vegf抗体的优化的变体
CN105353136A (zh) * 2015-12-01 2016-02-24 北京健平九星生物医药科技有限公司 基于量子点CdSe检测人血清中VEGF浓度的试剂盒及其使用方法
CN109477843A (zh) 2016-07-15 2019-03-15 豪夫迈·罗氏有限公司 用于检测总vegf-a的水平的方法和手段
US11185552B2 (en) 2016-11-16 2021-11-30 Ichor, Llc Inhibitors of glucose-6-phosphate dehydrogenase for treating cardiovascular and pulmonary conditions
CN107677808A (zh) * 2017-08-04 2018-02-09 苏州浩欧博生物医药有限公司 一种甲状腺球蛋白的定量检测试剂盒及其制备方法和检测方法
CN111808191A (zh) * 2020-05-11 2020-10-23 廊坊天光生物技术有限公司 一种用于检测血清中vegf含量的抗体对及其用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE337223B (de) 1967-05-23 1971-08-02 Pharmacia Ab
US3720760A (en) 1968-09-06 1973-03-13 Pharmacia Ab Method for determining the presence of reagin-immunoglobulins(reagin-ig)directed against certain allergens,in aqueous samples
US3691016A (en) 1970-04-17 1972-09-12 Monsanto Co Process for the preparation of insoluble enzymes
CA1023287A (en) 1972-12-08 1977-12-27 Boehringer Mannheim G.M.B.H. Process for the preparation of carrier-bound proteins
US4195128A (en) 1976-05-03 1980-03-25 Bayer Aktiengesellschaft Polymeric carrier bound ligands
US4330440A (en) 1977-02-08 1982-05-18 Development Finance Corporation Of New Zealand Activated matrix and method of activation
CA1093991A (en) 1977-02-17 1981-01-20 Hideo Hirohara Enzyme immobilization with pullulan gel
US4229537A (en) 1978-02-09 1980-10-21 New York University Preparation of trichloro-s-triazine activated supports for coupling ligands
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
IT8423926V0 (it) * 1984-11-29 1984-11-29 Eurodomestici Ind Riunite Disposizione per rimuovere detersivi e prodotti di lavaggio in genere dagli scomparti dei cassetti di macchine lavabiancheria domestiche.
US5620845A (en) 1988-06-06 1997-04-15 Ampcor, Inc. Immunoassay diagnostic kit
US5219739A (en) 1989-07-27 1993-06-15 Scios Nova Inc. DNA sequences encoding bVEGF120 and hVEGF121 and methods for the production of bovine and human vascular endothelial cell growth factors, bVEGF120 and hVEGF121
JPH05504841A (ja) 1990-09-14 1993-07-22 バイオサイト・ダイアグノスティックス・インコーポレイテッド リガンドレセプター及びリガンドのコンプレックスに対する抗体及びリガンド―レセプターアッセーでのそれらの用途
US5434087A (en) 1993-02-24 1995-07-18 Abbott Laboratories Folate immunoassay utilizing folate binding protein in a multiclonal antibody format
CA2184584C (en) * 1994-03-08 2003-04-08 Jing-Shan Hu Vascular endothelial growth factor 2
JPH08245424A (ja) * 1995-03-06 1996-09-24 Toagosei Co Ltd 糖尿病性腎症診断剤
JP3591264B2 (ja) * 1997-12-24 2004-11-17 富士レビオ株式会社 Ｖｅｇｆ１２１特異的モノクローナル抗体及び測定方法
ATE315789T1 (de) * 1999-11-16 2006-02-15 Genentech Inc Elisa für vegf

Also Published As

Publication number Publication date
WO2001036972A2 (en) 2001-05-25
CA2387390C (en) 2009-01-06
CN1420987A (zh) 2003-05-28
US6855508B2 (en) 2005-02-15
JP2003515136A (ja) 2003-04-22
IL149171A (en) 2008-06-05
US20030044865A1 (en) 2003-03-06
IL149171A0 (en) 2002-11-10
CN100399030C (zh) 2008-07-02
DE60025526T2 (de) 2006-08-24
EP1230552B1 (de) 2006-01-11
EP1230552A2 (de) 2002-08-14
KR20020070434A (ko) 2002-09-09
AU774575C (en) 2005-09-08
NZ518363A (en) 2003-01-31
WO2001036972A3 (en) 2002-01-03
US7541160B2 (en) 2009-06-02
KR100749982B1 (ko) 2007-08-16
AU774575B2 (en) 2004-07-01
ZA200202942B (en) 2003-06-25
ATE315789T1 (de) 2006-02-15
US20070202558A1 (en) 2007-08-30
ES2256066T3 (es) 2006-07-16
AU1613401A (en) 2001-05-30
CA2387390A1 (en) 2001-05-25
JP4620312B2 (ja) 2011-01-26

Similar Documents

Publication Publication Date Title
ATE315789T1 (de) Elisa für vegf
MX342791B (es) Ensayo elisa para la detección de vegf.
ATE348843T1 (de) Nachweis von tsh-rezeptor-autoantikörpern mit affinitätsgereinigten antikörpern
WO2005108989A3 (en) Assay for antibodies
NO904001D0 (no) Fremgangsmaate og anordning for amperometrisk diagnoseanalyse.
DE69631738D1 (de) Medizinische implantierbare Vorrichtung für elektrochemische Messungen von Bluteigenschaften
ATE312946T1 (de) Verfahren und vorrichtung zur bestimmung der gewebespezifität von freier dna in körperflüssigkeiten
WO2001040517A3 (en) Evaluating and predicting clinical outcomes by gene expression analysis
CN101025415A (zh) 一种检测尿液中尿酸含量范围的试纸
DE3870405D1 (de) Testvorrichtung zur bestimmung von okkultem blut und glukose.
ATE126599T1 (de) Verfahren zur bestimmung von anti-rns- antikörpern.
Hu et al. Detection of hypoxic fractions in murine tumors by comet assay: comparison with other techniques
Hemphill Tooth size apportionment among contemporary Indians: An analysis of caste, language, and geography.
DE502004012230D1 (de) Verfahren zur diagnose von erkrankungen unter bestimmung von apolipoprotein c-i
WO1992005278A3 (en) Method for the determination of the differential expression of mrna for the amyloid precursor protein (app)
ATE155891T1 (de) Immunoassay für nca-bt in blutproben von brustkrebspatientinnen
FR2840905B1 (fr) Anticorps monoclonal anti-aurora-a, son procede d'obtention, et ses utilisations dans le diagnostic et le traitement des cancers
Stamler et al. More on dietary sodium and blood pressure
Goodson Application of expanded polytetrafluoroethylene (ePTFE) tubing to the study of human wound healing
SU1608462A1 (ru) Способ диагностики неспецифической диабетической нефропатии
RU2001113027A (ru) Способ диагностики тканевой инсулинорезистентности у различной категории кардиологических больных
ATE220458T1 (de) Pyridinolin-quervernetzung als hinweis auf krankhafte vorgänge an periodontalen und peripheren implantaten
Estabrooks Gender patterns and behaviours to manage early recovery following coronary artery bypass surgery.
RU2000111313A (ru) Способ диагностики травматической жировой эмболии
Mayhugh Alcohol treatment programs: A multisite naturalistic study.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition